Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts
Authors:
- Masaya KinoMKMasaya Kino
- Yuzo HirotaYHYuzo Hirota
- Shoji YamamotoSYShoji Yamamoto
- Kenichi SawadaKSKenichi Sawada
- Masatomo MoriguchiMMMasatomo Moriguchi
- Masahiro KotakaMKMasahiro Kotaka
- Shinichiro KuboSKShinichiro Kubo
- Keishiro KawamuraKKKeishiro Kawamura
- 1 March 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (5) , 802-810
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.Circulation, 1981
- Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.Circulation, 1981
- Long-Term Vasodilator Therapy with Trimazosin in Chronic Cardiac FailureNew England Journal of Medicine, 1980
- Oral amrinone in refractory congestive heart failureThe American Journal of Cardiology, 1980
- Long-term therapy of heart failure with prazosin: A randomized double blind trialThe American Journal of Cardiology, 1980
- Haemodynamic effects of prenalterol in patients with coronary heart disease.Heart, 1980
- Salbutamol in treatment of heart failure.Heart, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Long-term outpatient vasodilator therapy of congestive heart failureThe American Journal of Medicine, 1978
- Usefulness of long-acting nitrates in cardiovascular diseaseThe American Journal of Medicine, 1978